| 1 |
20463304 | The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice. | 2010 May |
1 |
| 2 |
12821347 | Iron withdrawal strategies fail to prevent the growth of SiHa-induced tumors in mice. | 2003 Jul |
2 |
| 3 |
10397746 | The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation. | 1999 Jul 15 |
1 |
| 4 |
7641199 | Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor. | 1995 Sep 1 |
2 |
| 5 |
2858272 | Growth promotion of transformed cells by iron in serum-free culture. | 1985 Mar |
1 |
| 6 |
6296362 | Alterations of the [59Fe]ferric citrate biodistribution in hyperferremic mice after the administration of pyrophosphate and desferrioxamine. | 1983 Feb |
3 |